Daniel C. Cho
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Renal cell carcinoma treatment 18
- Oncology 11
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Michael B. Atkins (12 shared papers)Chiara Battelli (1 shared paper)James Walter Mier (6 shared papers)David F. McDermott (9 shared papers)Toni K. Choueiri (6 shared papers)David J. Panka (2 shared papers)Igor J. Puzanov (5 shared papers)Sabina Signoretti (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (5 papers)Clinical Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Cancer Discovery (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Daniel C. Cho
41 papers receiving 2.5k citations
Daniel C. Cho's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 730
- Pulmonary and Respiratory Medicine 707
- Drug Discovery 4
- Molecular Biology 742
- Cancer Research 155
Countries citing papers authored by Daniel C. Cho
This map shows the geographic impact of Daniel C. Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Cho more than expected).
Fields of papers citing papers by Daniel C. Cho
This network shows the impact of papers produced by Daniel C. Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Cho. The network helps show where Daniel C. Cho may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Cho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement Hit paper breakdown → | 2013 | 606 |
| 2 | Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial Hit paper breakdown → | 2018 | 311 |
| 3 | Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial Hit paper breakdown → | 2023 | 222 |
| 4 | 2020 | 211 | |
| 5 | 2010 | 166 | |
| 6 | 2021 | 103 | |
| 7 | 2011 | 98 | |
| 8 | 2012 | 87 | |
| 9 | 2010 | 75 | |
| 10 | 2021 | 68 | |
| 11 | 2022 | 61 | |
| 12 | 2022 | 55 | |
| 13 | 2007 | 48 | |
| 14 | 2023 | 44 | |
| 15 | 2021 | 42 | |
| 16 | 2009 | 39 | |
| 17 | 2012 | 39 | |
| 18 | 2020 | 27 | |
| 19 | 2016 | 26 | |
| 20 | 2013 | 23 |
About Daniel C. Cho
Daniel C. Cho is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 41 papers that have together received 2.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (11 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Melanoma and MAPK Pathways (3 papers), Cell death mechanisms and regulation (2 papers), Pericarditis and Cardiac Tamponade (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Oncology (730 citations), Pulmonary and Respiratory Medicine (707 citations), Drug Discovery (4 citations), Molecular Biology (742 citations) and Cancer Research (155 citations). Daniel C. Cho has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Michael B. Atkins, Chiara Battelli, James Walter Mier, David F. McDermott, Toni K. Choueiri, David J. Panka, Igor J. Puzanov, Sabina Signoretti, Saby George and Jamal Tarazi. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Journal of Clinical Oncology, Cancer Discovery and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.